Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has cleared ...

Force Factor has one goal in mind and that is to make individuals more powerful, stronger and faster. Two Harvard University rowers in 2009 founded Force Factor. Even though the company is still young ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and ...

Marvel Strike Force is a turn-based strategy that will please even the most hardcore fans of the franchise. The game features an impressive roster—from iconic fan favorites to more obscure superheroes ...